PALB2 and ovarian carcinoma: The detection of PALB2 and CHEK2 PGVs, in addition to PGVs detected in BRCA1/2, in breast/ovarian cancer is important for accurate risk assessment and the activation of subsequent cancer prevention and early detection strategies in the individual and their family.